Oncocross Co., Ltd. (KOSDAQ:382150)
South Korea · Delayed Price · Currency is KRW 10,890
-430 (-3.80%)
Jul 21, 2025, 2:40 PM KST
Oncocross Market Cap
Oncocross has a market cap or net worth of 135.25 billion as of July 18, 2025.
Market Cap
135.25B
Enterprise Value
118.67B
Revenue
1.07B
Ranking
n/a
PE Ratio
n/a
Stock Price
10,890.00
Market Cap Chart
Since December 18, 2024, Oncocross's market cap has increased from 106.25B to 135.25B, an increase of 27.30%. That is a compound annual growth rate of 51.52%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 18, 2025 | 135.25B | 79.90% |
| Dec 30, 2024 | 75.18B | -29.24% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 74.80T |
| Celltrion | 39.82T |
| ALTEOGEN | 26.19T |
| Yuhan | 9,866.54B |
| SK Biopharmaceuticals | 8,066.26B |
| HLB Co., Ltd. | 6,939.04B |
| Peptron | 6,861.07B |
| PharmaResearch | 5,890.93B |